Early Low-Dose Rituximab for Mild-to-Moderate Thyroid Eye Disease: A Preliminary Evaluation of Efficacy and Safety.

Int J Endocrinol · 2026 · PMC12800737 · PMID 41541752

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Notably, cortisol levels decreased significantly after treatment compared to baseline ( p = 0.043), while adrenocorticotropic hormone (ACTH) levels decreased, though this difference did not reach statistical significance (Table 1 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.